Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4+Foxp3+ T cells

M. C. Minnema*, M. S. van der Veer, T. Aarts, M. Emmelot, T. Mutis, H. M. Lokhorst

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)605-607
Number of pages3
JournalLeukemia
Volume23
Issue number3
DOIs
Publication statusPublished - 1 Jan 2009

Cite this